...
首页> 外文期刊>Journal of drug issues >Relying on Injection Drug Users to Access and Adhere to HIV Therapeutics: Bittersweet Lessons Using Respondent-Driven Sampling and a Peer-Driven Intervention
【24h】

Relying on Injection Drug Users to Access and Adhere to HIV Therapeutics: Bittersweet Lessons Using Respondent-Driven Sampling and a Peer-Driven Intervention

机译:依靠注射吸毒者获得和坚持使用HIV治疗方法:使用响应者驱动的抽样和对等驱动的干预获得苦乐参半的教训

获取原文
获取原文并翻译 | 示例

摘要

Results are presented of enrolling HIV+ active-injection drug users (IDUs) into a peer-driven intervention (PDI) to improve their adherence to medical care. Using respondent-driven sampling (RDS), which evolved out of the PDI model, the authors recruited and tested 1,097 IDUs, of whom 145 were confirmed to be HIV+. Despite promises of confidentiality, increased social supports, and direct cash rewards for participating, only 78 (54%) of the HIV+ IDUs enrolled in the subsequent adherence study. Correlates of participation as well as interviews with respondents who declined participating are presented. The seemingly negative findings have important implications for future adherence studies. RDS provided a powerful mechanism for recruiting HIV+ IDUs. But selection biases were revealed to favor sicker yet more socially connected respondents, which resulted in more conservative outcomes with regard to social supports and positive health-seeking behaviors. The analysis may help streamline future efforts using the PDI, which harnesses IDUs' abilities to help one another, by underscoring some of the mechanism's limitations.
机译:展示了将HIV +主动注射吸毒者(IDU)纳入同伴驱动的干预措施(PDI)中的结果,以改善他们对医疗保健的依从性。使用从PDI模型演变而来的响应者驱动抽样(RDS),作者招募和测试了1,097个注射毒品者,其中145个被确认为HIV +。尽管承诺保密,增加了社会支持,并为参与提供直接现金奖励,但随后的依从性研究仅招募了78名(54%)HIV + IDU。介绍了参与的相关性以及对拒绝参与的受访者的访谈。似乎是负面的发现对未来的依从性研究具有重要意义。 RDS提供了一个强大的机制来招募HIV + IDU。但是发现选择偏见倾向于偏重病态但与社会联系更多的受访者,这导致在社会支持和积极的健康追求行为方面更为保守的结果。通过强调机制的某些局限性,该分析可能有助于利用PDI简化未来的工作,该PDI利用IDU的能力互相帮助。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号